COVID-19, Australia: Epidemiology Report 2  Reporting week ending 19:00 AEDT 8 February 2020

Walker, Liz J

doi:10.33321/cdi.2020.44.14

Cited by 12 publications

(10 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In December 2019, an outbreak of coronavirus disease (COVID-19) due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China, and spread rapidly to other areas of China and other countries. [1][2][3][4][5][6] Phylogenetic analysis suggests that SARS-CoV-2 is a new human-infecting betacoronavirus, closely similar to bat coronaviruses, suggesting that bats may have been the original host of this virus. 7 There are no antiviral drugs of proven efficacy or applicable vaccines.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 in Hemodialysis Patients: A Report of 5 Cases

Wang

Liao

et al. 2020

American Journal of Kidney Diseases

165

145

View full text Add to dashboard Cite

, an outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this case report, we describe the clinical and epidemiologic features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 patients with COVID-19 infection, one had a definite history of contact with an infected person. The age range of the patients was 47 to 67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients. Computed tomography of the chest showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, or multiple organ dysfunction) or died. Complete author and article information provided before references.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19 in Hemodialysis Patients: A Report of 5 Cases

Wang

Liao

et al. 2020

American Journal of Kidney Diseases

165

145

View full text Add to dashboard Cite

show abstract

“…Figure 1 compares the expected number of importations for the two scenarios. The first travel ban that was implemented by the Australian government affected foreign nationals travelling from, and transiting through China within the last 14 days prior to arrival 14 . Figure 1 shows a clear reduction in the expected number of importations after this restriction came into effect on 1 st February 2020, compared to the open border scenario.…”

Section: Resultsmentioning

confidence: 99%

Should international borders re-open? The impact of travel restrictions on COVID-19 importation risk

Liebig

Najeebullah

Jurdak

et al. 2020

Preprint

View full text Add to dashboard Cite

Novel coronavirus disease (COVID-19) has spread across the world at an unprecedented pace, reaching over 200 countries and territories in less than three months. In response, many governments denied entry to travellers arriving from various countries affected by the virus. While several industries continue to experience economic losses due to the imposed interventions, it is unclear whether the different travel restrictions were successful in reducing COVID-19 importations. Here we develop a comprehensive framework to model daily COVID-19 importations, considering different travel bans. We quantify the temporal effects of the restrictions and elucidate the relationship between incidence rates in other countries, travel flows and the expected number of importations into the country under investigation. As a cases study, we evaluate the travel bans enforced by the Australian government. We find that international travel bans in Australia lowered COVID-19 importations by 87.68% (83.39 - 91.35) between January and June 2020. The presented framework can further be used to gain insights into how many importations to expect should borders re-open. Authorities may consider the presented information when planning a phased re-opening of international borders.

show abstract

“…Provincial travels to China and travels from China to other countries led to the spread of COVID-19 [18], so that in the 2 nd Epidemiology Report of Australia, 80% of patients mentioned the history of recent travel to China [18]. The first cases of coronavirus infection in Italy were related to travelers traveling from China to this country [2].…”

Section: Resultsmentioning

confidence: 99%

The COVID-19 pandemic: a systematic review of the current evidence

Ghomi¹,

Asgari²,

Hajiheydari³

et al. 2020

Russian Journal of Infection and Immunity

View full text Add to dashboard Cite

Introduction: An epidemic of Coronavirus Disease 2019 (COVID-19) begun in December 2019 in China, causing primary concern. Among raised questions, due to the rapid spread of the disease worldwide. Among the questions raised, disease epidemiology, clinical, laboratory symptoms and radiological findings and treatment of COVID-19 disease have been identified in some studies. But no systematic review on current evidences about COVID-19 has been published. Objective: The aim of this study was to determine the COVID-19 epidemiology, clinical features , diagnosis and treatment.Data sources: We performed a systematic review of the literature, using the keywords: "coronavirus" and "2020", "COVID-19" in databases: Science Direct, PubMed, Springer and Scopus during January 1, 2020 to February 23, 2020.Study Selection: All observational studies, as well as case reports and editorial that published in English were included.Data Extraction: Data on the disease control methods of COVID-19 were extracted by multiple observers.Results: 131 articles were retrieved. After screening by abstract and title, 58 articles were selected for full-text assessment. Of them, 43 were finally included for review. The COVID-19 has spread rapidly and can be transmitted via close human-to human contact via nasopharyngeal or oropharyngeal droplets. The COVID-19, causing considerable problems, especially in patients with comorbidities and old patients. Fever, cough, sore throat and diarrhea are the main clinical features of this emerging disease. The most common radiological finding is bilateral grand glass view and LOPINAVIR and RITONAVIR are among the antiviral drugs used.Conclusion: COVID-19 is a new clinical infectious disease and can be a serious problem for health systems. additional research is needed to elucidate factors that may mediate the pathogenesis of the severe and fatal associated disease.

show abstract

COVID-19, Australia: Epidemiology Report 2 Reporting week ending 19:00 AEDT 8 February 2020

Cited by 12 publications

References 14 publications

COVID-19 in Hemodialysis Patients: A Report of 5 Cases

COVID-19 in Hemodialysis Patients: A Report of 5 Cases

Should international borders re-open? The impact of travel restrictions on COVID-19 importation risk

The COVID-19 pandemic: a systematic review of the current evidence

Contact Info

Product

Resources

About